| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $228K | +7.2% | -70.1% |
| Cost of Revenue | $214K | -43.2% | -74.5% |
| R&D Expense | $2.8M | -11.8% | -22.6% |
| SG&A Expense | $3.0M | -25.2% | -40.2% |
| Operating Income | -$5.8M | +58.1% | +33.6% |
| Pre-tax Income | -$4.3M | +61.7% | +53.5% |
| Net Income | -$4.1M | +61.9% | +54.0% |
| EPS (Basic) | -$0.09 | +92.2% | +99.7% |
| EPS (Diluted) | -$0.09 | +92.2% | +99.7% |
| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $521K | +175.5% | -64.6% |
| Short-term Investments | $135K | +124.3% | +292.6% |
| Accounts Receivable | $25K | -88.1% | -98.1% |
| Inventory | $204K | +0.0% | +187.6% |
| Current Assets | $1.5M | -26.1% | -56.4% |
| Total Assets | $21.6M |
| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.8M | -101.0% | — |
| Capital Expenditures | $58K | +0.0% | — |
| Investing Cash Flow | $77K | +350.5% | — |
| Financing Cash Flow | $6.2M | +146.2% | — |
| Free Cash Flow | -$6.8M | -99.3% | — |
| -53.8% |
| Current Liabilities | $23.3M | +0.6% | +115.1% |
| Total Liabilities | $29.5M | -2.2% | +18.8% |
| Stockholders' Equity | -$2.5M | -81.8% | -109.7% |